CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | +39.1% | +268.0% | +88.3% | +6.9% | -2.7% | +6.6% | +11.7% | +153.6% | +39.7% | |
| – | +0.4% | +756.1% | +171.3% | +65.7% | +66.4% | +62.9% | +44.8% | +69.5% | +31.2% | |
| – | +0.4% | +596.3% | +233.3% | +66.3% | +62.8% | +70.9% | – | – | – | |
| – | -481.5% | – | -140.3% | – | +191.5% | +1,598.2% | -56.8% | +44.6% | -58.4% | |
| – | +60.0% | +248.4% | -53.5% | -62.2% | +134.4% | +279.8% | +183.1% | -18.0% | +49.9% | |
| – | +60.0% | +39,195.4% | – | -99.5% | -26,129.0% | +208.0% | +15.2% | +186.8% | – | |
| – | – | +1,314.2% | -100.0% | – | -100.0% | – | – | +2,669.3% | -100.0% | |
| – | +341.7% | – | – | – | – | – | – | – | – | |
| – | – | +1,339.6% | -100.0% | +170,901.5% | +120.5% | -51.7% | +218.9% | +159.8% | -96.0% | |
| – | – | +1,433.4% | -114.9% | – | +104.0% | -255.4% | – | +843.3% | -178.0% | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.